Premium
Diffusion‐weighted echo‐planar magnetic resonance imaging for the assessment of tumor cellularity in patients with soft‐tissue sarcomas
Author(s) -
Schnapauff Dirk,
Zeile Martin,
Niederhagen Manuel Ben,
Fleige Barbara,
Tunn PerUlf,
Hamm Bernd,
Dudeck Oliver
Publication year - 2009
Publication title -
journal of magnetic resonance imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.563
H-Index - 160
eISSN - 1522-2586
pISSN - 1053-1807
DOI - 10.1002/jmri.21755
Subject(s) - medicine , effective diffusion coefficient , magnetic resonance imaging , soft tissue , grading (engineering) , biopsy , diffusion mri , radiology , nuclear medicine , civil engineering , engineering
Purpose To investigate the eligibility of diffusion‐weighted imaging (DWI) for the evaluation of tumor cellularity in patients with soft‐tissue sarcomas. Materials and Methods Thirty consecutive patients with a total of 31 histologically‐proven soft‐tissue sarcomas prospectively underwent magnetic resonance imaging (MRI) including DWI with echo‐planar imaging (EPI) technique immediately before open biopsy ( N = 1) or tumor resection ( N = 30). Fourteen patients had no previous anticancer treatment, 16 had received neoadjuvant therapy. Tumor cellularity as determined from histological sections was compared with minimum apparent diffusion coefficient (ADC). Results Tumor cellularity correlated well with minimum ADC in a linear fashion, with a Pearson correlation coefficient of –0.88 (95% confidence interval [CI]: –0.75 to –0.96). This relationship was not influenced by prior anticancer treatment. There was only a tendency toward lower ADC in tumor with higher grading but no significant dependency ( P = 0.08). Conclusion DWI has proven useful for the assessment of tumor cellularity in soft‐tissue sarcomas. In result, DWI may be used as a powerful noninvasive tool to monitor responses of cytotoxic treatment as reflected by changes in tumor cellularity. J. Magn. Reson. Imaging 2009. © 2009 Wiley‐Liss, Inc.